Keratin Biomaterials for Cranio-facial Tissue Engineering

Award Information
Agency: Department of Defense
Branch: Army
Contract: W81XWH-10-C-0165
Agency Tracking Number: O093-H10-3014
Amount: $99,260.00
Phase: Phase I
Program: SBIR
Awards Year: 2010
Solicitation Year: 2009
Solicitation Topic Code: OSD09-H10
Solicitation Number: 2009.3
Small Business Information
KeraNetics, LLC
1st Floor, Richard Dean Building, 391 Technology Way, Winston-Salem, NC, 27101
DUNS: 827054219
HUBZone Owned: Y
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Luke Burnett
 Senior Scientist
 (336) 202-1307
 luke.burnett@keranetics.com
Business Contact
 Kim Westmoreland
Title: Co-Managing Director
Phone: (336) 918-6405
Email: kim.westmoreland@keranetics.com
Research Institution
N/A
Abstract
The majority of personnel injured in OIF/OEF have suffered blast effects from IEDs. Blasts often cause cranio-facial trauma that is difficult to repair. There is a significant need to develop better platform technologies for these injuries and translate them into clinical and commercial use. A family of biomaterials derived from keratin proteins may provide a platform on which regenerative strategies can be built. Keratins have broad biocompatibility and can be formulated as films, foams, gels, fibers, or solid tissue constructs. One of the problems with many synthetic and naturally derived biomaterials is that they do not promote cell adhesion and migration into scaffolds that have weak cell-matrix interactions. Keratins have intrinsic cell-binding properties that can be exploited to offer potential new solutions to cranio-facial regeneration. This Phase I proposal seeks to perform initial testing of keratin materials using primary cell types relevant to cranio-facial tissues. Assessments will be made regarding cell attachment, proliferation, gene expression and other cell specific assays to validate that keratin materials provide a permissive extracellular matrix-like environment. Results will be used to tailor specific types of keratin proteins into biomaterial scaffolds for use in large animal cranio-facial defect studies to be conducted in Phase II.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government